{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:41:40Z","timestamp":1789429300100,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Consistent with their diverse pharmacology, peptides derived from venomous animals have been developed as drugs to treat disorders as diverse as hypertension, diabetes and chronic pain. Melanoma has a poor prognosis due in part to its metastatic capacity, warranting further development of novel targeted therapies. This prompted us to examine the anti-melanoma activity of the spider peptides gomesin (AgGom) and a gomesin-like homolog (HiGom). AgGom and HiGom dose-dependently reduced the viability and proliferation of melanoma cells whereas it had no deleterious effects on non-transformed neonatal foreskin fibroblasts. Concordantly, gomesin-treated melanoma cells showed a reduced G0\/G1 cell population. AgGom and HiGom compromised proliferation of melanoma cells via activation of the p53\/p21 cell cycle check-point axis and the Hippo signaling cascade, together with attenuation of the MAP kinase pathway. We show that both gomesin peptides exhibit antitumoral activity in melanoma AVATAR-zebrafish xenograft tumors and that HiGom also reduces tumour progression in a melanoma xenograft mouse model. Taken together, our data highlight the potential of gomesin for development as a novel melanoma-targeted therapy.<\/jats:p>","DOI":"10.1038\/s41598-018-29826-4","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T09:04:54Z","timestamp":1532595894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation"],"prefix":"10.1038","volume":"8","author":[{"given":"Maria P.","family":"Ikonomopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel A.","family":"Fernandez-Rojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9003-0101","authenticated-orcid":false,"given":"Sandy S.","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Cabezas-Sainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Winnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo A. V.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Brust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Alewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7058-6201","authenticated-orcid":false,"given":"Grant A.","family":"Ramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn F.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"key":"29826_CR1","unstructured":"Natural History Museum, B. World Spider Catalog v16., http:\/\/wsc.nmbe.ch (2015)."},{"key":"29826_CR2","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1098\/rstb.2015.0133","volume":"371","author":"J Lozano-Fernandez","year":"2016","unstructured":"Lozano-Fernandez, J. et al. A molecular palaeobiological exploration of arthropod terrestrialization. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 371, 1699 (2016).","journal-title":"Philos. Trans. R. Soc. Lond. B: Biol. Sci."},{"key":"29826_CR3","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.dci.2007.11.002","volume":"32","author":"AH Fukuzawa","year":"2008","unstructured":"Fukuzawa, A. H. et al. The role of hemocytes in the immunity of the spider Acanthoscurria gomesiana. Dev. Comp. Immunol. 32, 716\u2013725 (2008).","journal-title":"Dev. Comp. Immunol."},{"issue":"6","key":"29826_CR4","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/bioinformatics\/btx661","volume":"34","author":"SS Pineda","year":"2018","unstructured":"Pineda, S. S. et al. ArachnoServer 3.0, an online resource for automated discovery, analysis and annotation of spider toxins. Bioinformatics. 34(6), 1074\u20131076 (2018).","journal-title":"Bioinformatics."},{"key":"29826_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-ento-120811-153650","volume":"58","author":"GF King","year":"2013","unstructured":"King, G. F. & Hardy, M. C. Spider-venom peptides: structure, pharmacology, and potential for control of insect pests. Annu. Rev. Entomol. 58, 475\u2013496 (2013).","journal-title":"Annu. Rev. Entomol."},{"key":"29826_CR6","doi-asserted-by":"publisher","first-page":"33464","DOI":"10.1074\/jbc.M001491200","volume":"275","author":"PI Silva","year":"2000","unstructured":"Silva, P. I., Daffre, S. & Bulet, P. Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family. J. Biol. Chem. 275, 33464\u201333470 (2000).","journal-title":"J. Biol. Chem."},{"key":"29826_CR7","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1046\/j.0014-2956.2002.02760.x","volume":"269","author":"N Mandard","year":"2002","unstructured":"Mandard, N., Bulet, P., Caille, A., Daffre, S. & Vovelle, F. The solution structure of gomesin, an antimicrobial cysteine-rich peptide from the spider. Eur. J. Biochem. 269, 1190\u20131198 (2002).","journal-title":"Eur. J. Biochem."},{"key":"29826_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1021\/acsinfecdis.6b00045","volume":"2","author":"IA Edwards","year":"2016","unstructured":"Edwards, I. A. et al. Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of \u03b2-hairpin peptides. ACS Infect. Dis. 2, 442\u2013450 (2016).","journal-title":"ACS Infect. Dis."},{"key":"29826_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.exppara.2007.01.022","volume":"116","author":"CK Moreira","year":"2007","unstructured":"Moreira, C. K. et al. Effect of the antimicrobial peptide gomesin against different life stages of Plasmodium spp. Exp. Parasitol. 116, 346\u2013353 (2007).","journal-title":"Exp. Parasitol."},{"key":"29826_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1574-6968.2007.00850.x","volume":"274","author":"FM Barbosa","year":"2007","unstructured":"Barbosa, F. M. et al. Gomesin, a peptide produced by the spider Acanthoscurria gomesiana, is a potent anticryptococcal agent that acts in synergism with fluconazole. FEMS Microbiol. Lett. 274, 279\u2013286 (2007).","journal-title":"FEMS Microbiol. Lett."},{"key":"29826_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1593\/neo.07885","volume":"10","author":"EG Rodrigues","year":"2008","unstructured":"Rodrigues, E. G. et al. Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin. Neoplasia 10, 61\u201368 (2008).","journal-title":"Neoplasia"},{"key":"29826_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","volume":"9","author":"BC Bastian","year":"2014","unstructured":"Bastian, B. C. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu. Rev. Pathol. Mech. Dis. 9, 239\u2013271 (2014).","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"29826_CR13","unstructured":"Melanoma skin cancer in Australia: melanoma of the skin statistics (https:\/\/melanoma.canceraustralia.gov.au\/statistics) (2016)."},{"key":"29826_CR14","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman, P. B. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med. 364, 2507\u2013251 (2011).","journal-title":"N. Engl. J. Med."},{"key":"29826_CR15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00008390-200010000-00001","volume":"10","author":"DJ Easty","year":"2000","unstructured":"Easty, D. J. & Bennett, D. C. Protein tyrosine kinases in malignant melanoma. Melanoma Res. 10, 401\u2013411 (2000).","journal-title":"Melanoma Res."},{"key":"29826_CR16","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1021\/acs.accounts.6b00074","volume":"49","author":"M-A Sani","year":"2016","unstructured":"Sani, M.-A. & Separovic, F. How membrane-active peptides get into lipid membranes. Acc. Chem. Res. 49, 1130\u20131138 (2016).","journal-title":"Acc. Chem. Res."},{"issue":"5","key":"29826_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/cbic.201300034","volume":"14","author":"LY Chan","year":"2013","unstructured":"Chan, L. Y. et al. Cyclization of the antimicrobial peptide gomesin with native chemical ligation: influences on stability and bioactivity. ChemBioChem 14(5), 617\u201324 (2013).","journal-title":"ChemBioChem"},{"key":"29826_CR18","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1124\/mol.111.076794","volume":"81","author":"C-W Zeng","year":"2012","unstructured":"Zeng, C.-W. et al. Camptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathways. Mol. Pharmacol. 81, 578\u2013586 (2012).","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"29826_CR19","doi-asserted-by":"publisher","first-page":"e1021441","DOI":"10.1080\/23723556.2015.1021441","volume":"3","author":"L Lin","year":"2015","unstructured":"Lin, L. & Bivona, T. G. The Hippo effector YAP regulates the response of cancer cells to MAPK pathway inhibitors. Mol. Cell. Oncol. 3(1), e1021441 (2015).","journal-title":"Mol. Cell. Oncol."},{"key":"29826_CR20","doi-asserted-by":"publisher","first-page":"21507","DOI":"10.18632\/oncotarget.4242","volume":"6","author":"A Heinemann","year":"2015","unstructured":"Heinemann, A. et al. Combining BET and HDAC inhibitors synergistically apoptosis of melanoma and suppresses AKT and YAP signaling. Oncotarget 6, 21507\u201321521 (2015).","journal-title":"Oncotarget"},{"key":"29826_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/ijc.29429","volume":"137","author":"H Yuan","year":"2015","unstructured":"Yuan, H. et al. Genetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survival. Int. J. Cancer 137, 638\u2013645 (2015).","journal-title":"Int. J. Cancer"},{"key":"29826_CR22","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1074\/jbc.271.2.963","volume":"271","author":"HML Edelmann","year":"1995","unstructured":"Edelmann, H. M. L., Kuhne, C., Petritsch, C. & Ballou, L. M. Cell cycle regulation of p70 S6 kinase and p42\/p44 Mitogen-activated protein kinases in swiss mouse 3T3 fibroblasts. J. Biol. Chem. 271, 963\u2013971 (1995).","journal-title":"J. Biol. Chem."},{"key":"29826_CR23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0968-0004(01)01958-2","volume":"26","author":"DP Brazil","year":"2001","unstructured":"Brazil, D. P. & Hemmings, B. A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26, 657\u2013664 (2001).","journal-title":"Trends Biochem. Sci."},{"key":"29826_CR24","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante, M., Sabatini & David, M. mTOR signaling in growth control and disease. Cell 149, 274\u2013293 (2012).","journal-title":"Cell"},{"issue":"4","key":"29826_CR25","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1128\/MCB.00601-09","volume":"30","author":"J Lous-Andre","year":"2010","unstructured":"Lous-Andre, J., Carriere, A., Moreau, J. & Roux, P. P. mTORC1-activated S6K1 phosphorylates rictor on treonine 1135 and regulates mTORC2 signaling. Mol. Cell. Biol. 30(4), 908\u2013921 (2010).","journal-title":"Mol. Cell. Biol."},{"key":"29826_CR26","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/onc.2009.401","volume":"29","author":"C Treins","year":"2010","unstructured":"Treins, C., Warne, P. H., Magnuson, M. A. & Pende, M. & Downward, J. Rictor is a novel target of p70 S6 kinase-1. Oncogene 29, 1003\u20131016 (2010).","journal-title":"Oncogene"},{"key":"29826_CR27","doi-asserted-by":"publisher","first-page":"20104","DOI":"10.1074\/jbc.M201745200","volume":"277","author":"M Saitoh","year":"2002","unstructured":"Saitoh, M. et al. Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylated site. J. Biol. Chem. 277, 20104\u201320112 (2002).","journal-title":"J. Biol. Chem."},{"key":"29826_CR28","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/pcmr.12370","volume":"28","author":"C Wellbrock","year":"2015","unstructured":"Wellbrock, C. & Arozarena, I. Microphthalmia-associated transcription factor in melanoma development and MAP-Kinase pathway targeted therapy. Pigment Cell Melanoma Res. 28, 390\u2013406 (2015).","journal-title":"Pigment Cell Melanoma Res."},{"key":"29826_CR29","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1038\/s41388-017-0036-8","volume":"37","author":"A Martinez-Ordonez","year":"2018","unstructured":"Martinez-Ordonez, A. et al. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis. Oncogene 37, 1430\u20131444 (2018).","journal-title":"Oncogene"},{"key":"29826_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-10-232","volume":"10","author":"Y Ayed","year":"2011","unstructured":"Ayed, Y. et al. Induction of cytotoxicity of Pelagia noctiluca venom causes reactive oxygen species generation, lipid peroxydation induction and DNA damage in human colon cancer cells. Lipids Health Dis. 10, 1\u201310 (2011).","journal-title":"Lipids Health Dis."},{"key":"29826_CR31","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1021\/mp300251j","volume":"9","author":"EJ Paredes-Gamero","year":"2012","unstructured":"Paredes-Gamero, E. J. et al. Cell-permeable gomesin peptide promotes cell death by intracellular Ca2+ overload. Mol. Pharm. 9, 2686\u20132697 (2012).","journal-title":"Mol. Pharm."},{"key":"29826_CR32","first-page":"494","volume":"21","author":"Y Zhang","year":"2009","unstructured":"Zhang, Y. et al. The role of endogenous reactive oxygen species in oxymatrine-induced caspase-3-dependent apoptosis in human melanoma A375cells. Preclinical report 21, 494\u2013501 (2009).","journal-title":"Preclinical report"},{"key":"29826_CR33","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.tcb.2010.04.005","volume":"20","author":"O Hyangyee","year":"2010","unstructured":"Hyangyee, O. & Irvine, K. D. Yorkie: the final destination of Hippo signaling. Trends Cell Biol. 20, 410\u2013417 (2010).","journal-title":"Trends Cell Biol."},{"key":"29826_CR34","doi-asserted-by":"publisher","first-page":"9666","DOI":"10.1073\/pnas.171301998","volume":"98","author":"H Harada","year":"2001","unstructured":"Harada, H., Andersen, J. S., Mann, M., Terada, N. & Korsmeyer, S. J. p70S6 kinase signals cell survival as well as growth inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci USA 98, 9666\u20139670 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"29826_CR35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.molonc.2014.02.006","volume":"8","author":"I Segatto","year":"2014","unstructured":"Segatto, I. et al. p70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation. Mol. Oncol. 8, 766\u2013780 (2014).","journal-title":"Mol. Oncol."},{"key":"29826_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1083\/jcb.201411128","volume":"211","author":"Z Zou","year":"2015","unstructured":"Zou, Z. et al. mTORC2 promotes cell survival through c-Myc-dependent up-regulation of E2F1. J. Cell Biol. 211, 105\u2013122 (2015).","journal-title":"J. Cell Biol."},{"key":"29826_CR37","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov, D. D., Guertin, D. A., Ali, S. M. & Sabatini, D. M. Phosphorylation and regulation of Akt\/PKB by the Rictor-mTOR Complex. Science 307, 1098\u20131101 (2005).","journal-title":"Science"},{"key":"29826_CR38","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1158\/1541-7786.MCR-09-0409","volume":"8","author":"D Boulbes","year":"2010","unstructured":"Boulbes, D. et al. Rictor Phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2. Mol. Cancer Res. 8, 896\u2013906 (2010).","journal-title":"Mol. Cancer Res."},{"key":"29826_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cbi.2010.04.012","volume":"186","author":"RC Soletti","year":"2010","unstructured":"Soletti, R. C. et al. Peptide gomesin triggers cell death through L-type channel calcium influx, MAPK\/ERK, PKC, PI3K signaling and generation of reactive oxygent species. Chem. Biol. Interact. 186, 135\u2013143 (2010).","journal-title":"Chem. Biol. Interact."},{"key":"29826_CR40","doi-asserted-by":"crossref","first-page":"11735","DOI":"10.18632\/oncotarget.4149","volume":"6","author":"Z Darzynkiewicz","year":"2015","unstructured":"Darzynkiewicz, Z. et al. Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21 WAF1, Cdt1 and the p12 subunit of DNA polymerase \u03b4 revealed in individual cells by cytometry. Oncotarget 6, 11735\u201311750 (2015).","journal-title":"Oncotarget"},{"key":"29826_CR41","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1158\/1535-7163.MCT-13-0011","volume":"12","author":"MS Carlino","year":"2013","unstructured":"Carlino, M. S. et al. Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and\/or MEK inhibition in melanoma. Cancer Therapeutics Insights 12, 1332\u20131342 (2013).","journal-title":"Cancer Therapeutics Insights"},{"key":"29826_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/365079a0","volume":"365","author":"A Dutta","year":"1993","unstructured":"Dutta, A., Ruppert, M. J., Aster, J. C. & Winchester, E. Inhibition of DNA replication factor RPA by p53. Nature 365, 79 (1993).","journal-title":"Nature"},{"key":"29826_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/15384101.2014.1000134","volume":"14","author":"V Gire","year":"2015","unstructured":"Gire, V. & Dulic, V. Senescence from G2 arrest, revisited. Cell Cycle 14, 297\u2013304 (2015).","journal-title":"Cell Cycle"},{"key":"29826_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-3-3","volume":"3","author":"R Pandey","year":"2010","unstructured":"Pandey, R., Nolte, V. & Schlotterer, C. CANGS: a user-friendly utility for processing and analyzing 454 GS-FLX data in biodiversity studies. BMC Res. Notes 3, 3 (2010).","journal-title":"BMC Res. Notes"},{"key":"29826_CR45","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1101\/gr.1917404","volume":"14","author":"B Chevreux","year":"2004","unstructured":"Chevreux, B. et al. Using the miraEST assembler for reliable and automated mRNA transcript assembly and SNP detection in sequenced ESTs. Genome Res. 14, 1147\u20131159 (2004).","journal-title":"Genome Res."},{"key":"29826_CR46","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/bioinformatics\/btp666","volume":"26","author":"I Milne","year":"2010","unstructured":"Milne, I. et al. Tablet: next generation sequence assembly visualization. Bioinformatics 26, 401\u2013402 (2010).","journal-title":"Bioinformatics"},{"key":"29826_CR47","unstructured":"Drummond, A. J. et al. Geneious v5.4 (2011)."},{"key":"29826_CR48","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nmeth.1701","volume":"8","author":"TN Petersen","year":"2011","unstructured":"Petersen, T. N., Brunak, S., von Heijne, G. & Nielsen, H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat. Meth. 8, 785\u2013786 (2011).","journal-title":"Nat. Meth."},{"key":"29826_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0076-6879(97)89041-6","volume":"289","author":"P Alewood","year":"1997","unstructured":"Alewood, P. et al. Rapid in situ neutralization protocols for Boc and Fmoc solid-phase chemistries. Methods Enzymol. 289, 14\u201329 (1997).","journal-title":"Methods Enzymol."},{"key":"29826_CR50","doi-asserted-by":"publisher","first-page":"12355","DOI":"10.1074\/jbc.M109.079012","volume":"285","author":"S Luo","year":"2010","unstructured":"Luo, S. et al. Atypical \u03b1-Conotoxin LtIA from Conus litteratus targets a novel microsite of the \u03b13\u03b22 nicotinic receptor. J. Biol. Chem. 285, 12355\u201312366 (2010).","journal-title":"J. Biol. Chem."},{"key":"29826_CR51","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1021\/np100648q","volume":"73","author":"EHL Tee","year":"2010","unstructured":"Tee, E. H. L. et al. Synthesis of essramycin and comparison of its antibacterial activity. J. Nat. Prod. 73, 1940\u20131942 (2010).","journal-title":"J. Nat. Prod."},{"key":"29826_CR52","unstructured":"Corbett, T. et al. In Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (eds Beverly A. Teicher & Paul A. Andrews) 99\u2013123 (Humana Press, 2004)."},{"key":"29826_CR53","unstructured":"Westerfield, M. The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio). 4th ed. University of Oregon Press; 2000."},{"key":"29826_CR54","unstructured":"Quantifish 1.1 Quantifish: fast, efficient analysis program for the quantification of fluorescence in zebrafish larvae. Zenodo, University College London, London, UK. https:\/\/zenodo.org\/record\/1182791 (2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29826-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29826-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29826-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:12:38Z","timestamp":1671610358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29826-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["29826"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-29826-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]},"assertion":[{"value":"24 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11519"}}